ABCB1 and ovarian carcinoma: Others such as perifosine [79], BEZ235 [80], and DHW-211 [81] have been reported to reverse drug resistance in ABCB1-overexpressing breast cancer, ovarian cancer, and NSCLC cell lines, respectively.